Market Closed -
Canadian Securities Exchange
09:49:31 2022-06-28 am EDT
|
5-day change
|
1st Jan Change
|
0.045
CAD
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
69.14
|
33.46
|
4.538
|
5.105
|
Enterprise Value (EV)
1 |
66.45
|
32.34
|
5.28
|
5.081
|
P/E ratio
|
-0.18
x
|
-4.44
x
|
-0.81
x
|
1.32
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-19.6
x
|
-4.03
x
|
-0.91
x
|
-2.25
x
|
EV / FCF
|
-381,337,739
x
|
-41,381,192
x
|
-6,048,361
x
|
-1,162,496
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
21.6
x
|
30.2
x
|
-1.12
x
|
-10.7
x
|
Nbr of stocks (in thousands)
|
111,520
|
113,438
|
113,438
|
113,438
|
Reference price
2 |
0.6200
|
0.2950
|
0.0400
|
0.0450
|
Announcement Date
|
7/30/20
|
6/3/21
|
1/26/24
|
1/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-0.8907
|
-3.389
|
-8.029
|
-5.816
|
-2.254
|
EBIT
1 |
-0.9003
|
-3.429
|
-8.36
|
-6.099
|
-2.272
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.9271
|
-11.61
|
-7.523
|
-5.623
|
3.857
|
Net income
1 |
-0.9271
|
-11.61
|
-7.523
|
-5.623
|
3.857
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-3.399
|
-0.0665
|
-0.0496
|
0.0340
|
Free Cash Flow
|
-
|
-0.1742
|
-0.7815
|
-0.873
|
-4.371
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/30/20
|
7/30/20
|
6/3/21
|
1/26/24
|
1/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
0.52
|
-
|
-
|
0.74
|
-
|
Net Cash position
1 |
-
|
2.7
|
1.12
|
-
|
0.02
|
Leverage (Debt/EBITDA)
|
-0.58
x
|
-
|
-
|
-0.1277
x
|
-
|
Free Cash Flow
|
-
|
-0.17
|
-0.78
|
-0.87
|
-4.37
|
ROE (net income / shareholders' equity)
|
-
|
-904%
|
-349%
|
381%
|
-170%
|
ROA (Net income/ Total Assets)
|
-
|
-98.6%
|
-155%
|
-168%
|
-146%
|
Assets
1 |
-
|
11.78
|
4.865
|
3.354
|
-2.634
|
Book Value Per Share
|
-
|
0.0300
|
0.0100
|
-0.0400
|
-0
|
Cash Flow per Share
|
-
|
0.0300
|
0.0100
|
0
|
0
|
Capex
1 |
0.04
|
-
|
0.06
|
0
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/30/20
|
7/30/20
|
6/3/21
|
1/26/24
|
1/26/24
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 3.73M | | -2.31% | 103B | | +0.56% | 95.28B | | +1.69% | 22.15B | | -17.37% | 21.02B | | -9.30% | 18.15B | | -41.01% | 16.74B | | -14.85% | 16.05B | | +3.21% | 13.68B | | +33.54% | 12.17B |
Bio Therapeutic Drugs
|